Melanoma Clinical Trials in Jerusalem
6 recruitingJerusalem, Israel
Showing 1–6 of 6 trials
Recruiting
Phase 2
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Malignant Melanoma
Merck Sharp & Dohme LLC160 enrolled38 locationsNCT06961006
Recruiting
Phase 1Phase 2
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Breast CancerColorectal, CancerGastric Cancer+4 more
Hadassah Medical Organization50 enrolled1 locationNCT00722228
Recruiting
Phase 1Phase 2
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Triple-Negative Breast CancerNon-small Cell Lung CancerMetastatic Cancer+6 more
Hadassah Medical Organization3 enrolled1 locationNCT05296564
Recruiting
Phase 1Phase 2
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Malignant Melanoma
Hadassah Medical Organization50 enrolled1 locationNCT01898039
Recruiting
Phase 3
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
MelanomaMetastatic MelanomaUnresectable Melanoma
Iovance Biotherapeutics, Inc.670 enrolled72 locationsNCT05727904
Recruiting
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Uveal Melanoma
Hadassah Medical Organization250 enrolled1 locationNCT01438658